Rheumatoid Arthritis: Independent Evidence on DMARDs, Omega-3, Curcumin & Supplements
DMARDs are standard of care; omega-3 fish oil is the best-supported supplement adjunct. Independent human-trial evidence, funding traced.
Evidence-graded research on heart and cardiovascular health — what trials and regulators show about omega-3, CoQ10 and other supplements, conflicts disclosed.
DMARDs are standard of care; omega-3 fish oil is the best-supported supplement adjunct. Independent human-trial evidence, funding traced.
Dissolves microclots? Modest BP effect, bleeding risk. Independent human-trial evidence, funding traced, evidence graded.
Nature’s Ozempic? LDL and glucose yes — weight loss, weak. Independent human-trial evidence, funding traced, evidence graded.
Key takeaways Strongest evidence: garlic supplementation modestly lowers blood pressure, roughly 3.7–4.4 mmHg systolic and 3.1–3.4 mmHg diastolic in non-industry-funded meta-analyses, concentrated in people who already have elevated blood pressure (Tang et al. 2025; Wang et al. 2015). Industry-linked meta-analyses from the same lead author who ran a Wakunaga-funded Aged Garlic Extract trial report larger … Read more
Key takeaways Strongest evidence: berberine 0.9–1.5 g/day lowers fasting glucose, post-meal glucose, and LDL/triglycerides in people with type 2 diabetes or metabolic syndrome, with effect sizes comparable to low-dose oral diabetes drugs in short trials (Wang et al. 2024 meta-analysis, Liu et al. 2025 meta-analysis). “Nature’s Ozempic” is not supported by the data — GLP-1 … Read more
Key takeaways Soluble fiber has the strongest LDL-lowering evidence: a meta-analysis of 181 RCTs found each 5 g/day increment reduced LDL-C by 8.28 mg/dL and total cholesterol by 10.82 mg/dL, with the review authors reporting no funding. Plant sterols/stanols reliably lower LDL-C (a 59-trial meta-analysis found a 0.31 mmol/L reduction), but a key older meta-analysis … Read more
Key takeaways WHO reports cardiovascular disease caused an estimated 19.8 million deaths in 2022 — about 32% of all global deaths — with heart attack and stroke accounting for 85% of that toll (WHO CVD fact sheet). A reanalysis of the PREDIMED trial (7,447 high-risk adults) found a Mediterranean diet supplemented with olive oil or … Read more
Key takeaways The strongest ingredient-level evidence is for food, not pills: a dose-response meta-analysis found every 10 g/day increase in dietary fiber was associated with a 10% lower colorectal cancer risk (RR 0.90), and three daily servings of whole grains were linked to a 17% lower risk (RR 0.83). A 47-trial meta-analysis (commissioned by WHO’s … Read more
Key takeaways WHO states about 38% of cancers can currently be prevented by avoiding known risk factors and applying evidence-based prevention strategies — meaningful risk reduction, not a guarantee (WHO cancer fact sheet). IARC classifies alcoholic beverages and processed meat as carcinogenic to humans, and red meat as probably carcinogenic — mainly for colorectal cancer … Read more
Key takeaways Best-supported use: statin-associated muscle pain — a meta-analysis of 12 RCTs (575 patients) found CoQ10 (100–200 mg/day) reduced statin-induced myalgia severity by ~30% (Qu et al., J Am Heart Assoc 2018). Moderate evidence: heart failure — the Q-SYMBIO trial (420 patients, 2 years) found 300 mg/day reduced major cardiovascular events by 43% in … Read more
Ask about anything on this page, or request the next deep dive: an ingredient, a supplement, or a health concern. We use published research, evidence syntheses, and regulatory guidance, with clear source links.